Polymorphisms of transforming growth factor beta 1 (RS#1800468 and RS#1800471) and esophageal squamous cell carcinoma among Zhuangese population, China

Gene

Volumn 512, Issue 1, 2013, Pages 1-5

  Tang, Ren Guang ^a   Huang, Yong Zhi ^a   Yao, Li Min ^a   Xiao, Jian ^a   Lu, Chuan ^a   Yu, Qian ^a  

^a YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

Author keywords

ESCC; Polymorphism; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CHINA; DNA EXTRACTION; DRINKING BEHAVIOR; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENOTYPE; HISTOLOGY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84868628845     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.10.009     Document Type: Article

References (31)

1. Amirghofran Z., Jalali S.A., Ghaderi A., Hosseini S.V. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer. Cancer Genet. Cytogenet. 2009, 190:21-25.
2. Derynck R., et al. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 1985, 316:701-705.
3. Fukai Y., et al. Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma. Int. J. Cancer 2003, 104:161-166.
4. Fukuchi M., et al. Plasma level of transforming growth factor beta1 measured from the azygos vein predicts prognosis in patients with esophageal cancer. Clin. Cancer Res. 2004, 10:2738-2741.
5. Garcia-Closas M., et al. Glutathione S-transferase mu and theta polymorphisms and breast cancer susceptibility. J. Natl. Cancer Inst. 1999, 91:1960-1964.
6. Grainger D.J., et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum. Mol. Genet. 1999, 8:93-97.
7. Guan X., Zhao H., Niu J., Tan D., Ajani J.A., Wei Q. Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. J. Exp. Clin. Cancer Res. 2009, 28:94.
8. Hartmann M.C., et al. Relationship between CCL5 and transforming growth factor-beta1 (TGFbeta1) in breast cancer. Eur. J. Cancer 2011, 47:1669-1675.
9. Hongo M., Nagasaki Y., Shoji T. Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity. J. Gastroenterol. Hepatol. 2009, 24:729-735.
10. Howell W.M., Turner S.J., Theaker J.M., Bateman A.C. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur. J. Immunogenet. 2003, 30:409-414.
11. Ignotz R.A., Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 1986, 261:4337-4345.
12. Katayama M., Shoji M., Satomi S. Differential growth properties of normal and malignant esophageal epithelial cells: a possible cross talk between transforming growth factor-beta1 and epidermal growth factor signaling. Tohoku J. Exp. Med. 2005, 206:61-71.
13. Koliopanos A., et al. Connective tissue growth factor gene expression alters tumor progression in esophageal cancer. World J. Surg. 2002, 26:420-427.
14. Liu D.S., et al. Effects of single nucleotide polymorphisms 869 T/C and 915 G/C in the exon 1 locus of transforming growth factor-beta1 gene on chronic obstructive pulmonary disease susceptibility in Chinese. Chin. Med. J. (Engl.) 2010, 123:390-394.
15. Long X.D., Ma Y., Zhou Y.F., Ma A.M., Fu G.H. Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population. Hepatology 2010, 52:1301-1309.
16. Lyons R.M., Keski-Oja J., Moses H.L. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J. Cell Biol. 1988, 106:1659-1665.
17. Lyons R.M., Gentry L.E., Purchio A.F., Moses H.L. Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J. Cell Biol. 1990, 110:1361-1367.
18. Mantel P.Y., Schmidt-Weber C.B. Transforming growth factor-beta: recent advances on its role in immune tolerance. Methods Mol. Biol. 2011, 677:303-338.
19. Mazur G., Bogunia-Kubik K., Wrobel T., Kuliczkowski K., Lange A. TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients. Cytokine 2006, 33:145-149.
20. Merogi A.J., Marrogi A.J., Ramesh R., Robinson W.R., Fermin C.D., Freeman S.M. Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas. Hum. Pathol. 1997, 28:321-331.
21. Morita M., et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int. J. Clin. Oncol. 2010, 15:126-134.
22. Nikolova P.N., et al. Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population. Cancer Immunol. Immunother. 2007, 56:371-379.
23. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108.
24. Peters C.A., et al. TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70:752-759.
25. Reis S.T., et al. Tgf-beta1 expression as a biomarker of poor prognosis in prostate cancer. Clinics 2011, 66:1143-1147.
26. Stanczuk G.A., Tswana S.A., Bergstrom S., Sibanda E.N. Polymorphism in codons 10 and 25 of the transforming growth factor-beta 1 (TGF-beta1) gene in patients with invasive squamous cell carcinoma of the uterine cervix. Eur. J. Immunogenet. 2002, 29:417-421.
27. Toh Y., et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int. J. Clin. Oncol. 2010, 15:135-144.
28. Wang L.D., et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat. Genet. 2010, 42:759-763.
29. Wei Y.S., Xu Q.Q., Wang C.F., Pan Y., Liang F., Long X.K. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma. Tissue Antigens 2007, 70:464-469.
30. Yang W.F., Yu J.M., Zuo W.S., Wang S.Z. Expression of CD80, CD86, TGF-beta1 and IL-10 mRNA in the esophageal carcinoma. Zhonghua Zhong Liu Za Zhi 2006, 28:762-765.
31. Zhang L., et al. Association of TGF-beta1 and XPD polymorphisms with severe acute radiation-induced esophageal toxicity in locally advanced lung cancer patients treated with radiotherapy. Radiother. Oncol. 2010, 97:19-25.